Editorial

Split Viewer

Blood Res 2015; 50(3):

Published online September 22, 2015

https://doi.org/10.5045/br.2015.50.3.123

© The Korean Society of Hematology

Biomarkers for hepatic sinusoidal obstruction syndrome after hematopoietic cell transplantation

Je-Hwan Lee, M.D. Ph.D.*

Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

REFERENCES

  1. Mohty, M, Malard, F, Abecassis, M, et al. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant, 2015;50;781-789.
    Pubmed
  2. Srivastava, A, Poonkuzhali, B, Shaji, RV, et al. Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation. Blood, 2004;104;1574-1577.
    Pubmed
  3. Seifert, C, Wittig, S, Arndt, C, Gruhn, B. Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation. J Cancer Res Clin Oncol, 2015;141;877-885.
    Pubmed
  4. Efrati, E, Zuckerman, T, Ben-Ami, E, Krivoy, N. MTHFR C677T/A1298C genotype: a possible risk factor for liver sinusoidal obstruction syndrome. Bone Marrow Transplant, 2014;49;726-727.
    Pubmed
  5. Elbahlawan, L, McArthur, J, Quasney, MW, et al. Association of IL-1β-511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation. J Pediatr Hematol Oncol, 2012;34;175-179.
    Pubmed
  6. Lee, JH, Lee, KH, Kim, S, et al. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study. Bone Marrow Transplant, 1998;22;883-888.
    Pubmed
  7. Lee, JH, Lee, KH, Lee, JH, et al. Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide. Br J Haematol, 2002;118;1087-1094.
    Pubmed
  8. Akil, A, Zhang, Q, Mumaw, CL, et al. Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transplant, 2015;21;1739-1745.
    Pubmed
  9. Yeom, MY, Kim, YJ, Chung, NG, et al. Hepatic veno-occlusive disease may develop in secondary iron overloaded mice after allogeneic hematopoietic stem cell transplantation with total body irradiation. Blood Res, 2015;50;140-146.
  10. Maradei, SC, Maiolino, A, de Azevedo, AM, Colares, M, Bouzas, LF, Nucci, M. Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood, 2009;114;1270-1275.
    Pubmed

Article

Editorial

Blood Res 2015; 50(3): 123-125

Published online September 22, 2015 https://doi.org/10.5045/br.2015.50.3.123

Copyright © The Korean Society of Hematology.

Biomarkers for hepatic sinusoidal obstruction syndrome after hematopoietic cell transplantation

Je-Hwan Lee, M.D. Ph.D.*

Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    References

    1. Mohty, M, Malard, F, Abecassis, M, et al. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant, 2015;50;781-789.
      Pubmed
    2. Srivastava, A, Poonkuzhali, B, Shaji, RV, et al. Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation. Blood, 2004;104;1574-1577.
      Pubmed
    3. Seifert, C, Wittig, S, Arndt, C, Gruhn, B. Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation. J Cancer Res Clin Oncol, 2015;141;877-885.
      Pubmed
    4. Efrati, E, Zuckerman, T, Ben-Ami, E, Krivoy, N. MTHFR C677T/A1298C genotype: a possible risk factor for liver sinusoidal obstruction syndrome. Bone Marrow Transplant, 2014;49;726-727.
      Pubmed
    5. Elbahlawan, L, McArthur, J, Quasney, MW, et al. Association of IL-1β-511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation. J Pediatr Hematol Oncol, 2012;34;175-179.
      Pubmed
    6. Lee, JH, Lee, KH, Kim, S, et al. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study. Bone Marrow Transplant, 1998;22;883-888.
      Pubmed
    7. Lee, JH, Lee, KH, Lee, JH, et al. Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide. Br J Haematol, 2002;118;1087-1094.
      Pubmed
    8. Akil, A, Zhang, Q, Mumaw, CL, et al. Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transplant, 2015;21;1739-1745.
      Pubmed
    9. Yeom, MY, Kim, YJ, Chung, NG, et al. Hepatic veno-occlusive disease may develop in secondary iron overloaded mice after allogeneic hematopoietic stem cell transplantation with total body irradiation. Blood Res, 2015;50;140-146.
    10. Maradei, SC, Maiolino, A, de Azevedo, AM, Colares, M, Bouzas, LF, Nucci, M. Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood, 2009;114;1270-1275.
      Pubmed
    Blood Res
    Volume 59 2024

    Stats or Metrics

    Share this article on

    • line

    Blood Research

    pISSN 2287-979X
    eISSN 2288-0011
    qr-code Download